Sio Capital Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-248,674
| Closed | -$2.58M | – | 58 |
|
2023
Q1 | $2.58M | Hold |
248,674
| – | – | 1.27% | 17 |
|
2022
Q4 | $2.48M | Hold |
248,674
| – | – | 0.92% | 19 |
|
2022
Q3 | $2.49M | Hold |
248,674
| – | – | 0.79% | 17 |
|
2022
Q2 | $2.49M | Hold |
248,674
| – | – | 0.94% | 27 |
|
2022
Q1 | $2.45M | Hold |
248,674
| – | – | 0.81% | 28 |
|
2021
Q4 | $2.48M | Hold |
248,674
| – | – | 0.75% | 36 |
|
2021
Q3 | $2.47M | Sell |
248,674
-51,326
| -17% | -$511K | 0.79% | 37 |
|
2021
Q2 | $3.06M | Hold |
300,000
| – | – | 0.76% | 42 |
|
2021
Q1 | $3M | Hold |
300,000
| – | – | 0.61% | 51 |
|
2020
Q4 | $3.2M | Buy |
+300,000
| New | +$3.2M | 0.65% | 50 |
|